These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5035837)

  • 21. Appropriate diagnostic technology in the management of cardiovascular diseases. Report of a WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1988; 772():1-41. PubMed ID: 3149080
    [No Abstract]   [Full Text] [Related]  

  • 22. The importance of blood pressure screening in children.
    Flynn JT; Falkner BE
    J Pediatr; 2009 Aug; 155(2):299; author reply 299-300. PubMed ID: 19619758
    [No Abstract]   [Full Text] [Related]  

  • 23. Report of cardiovascular screening of Florida physicians.
    Groover ME; Fulghum JE; Mahoney WW
    JFMA; 1972 Jun; 59(6):31-2. PubMed ID: 5038046
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary prevention and screening in adults: update 2006].
    Cornuz J; Guessous I; Rodondi N
    Rev Med Suisse; 2006 Jan; 2(50):262-73. PubMed ID: 16503042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular screening of student athletes.
    Searle A
    Am Fam Physician; 2001 Oct; 64(8):1326, 1328. PubMed ID: 11681775
    [No Abstract]   [Full Text] [Related]  

  • 26. Childhood prevention of hypertensive cardiovascular disease.
    Gillman MW
    J Pediatr; 2009 Aug; 155(2):159-61. PubMed ID: 19619745
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the circulatory system in workers in the cellulose-paper industry].
    Sinkiewicz W; Dziedziczko A; Hoffmann A
    Med Pr; 1998; 49(2):147-56. PubMed ID: 9695062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hospital-wide vascular screening program at the University Medical Center, Utrecht: prevalence of risk factors and asymptomatic vascular disease from 1996 to 2002].
    Visseren FL; de Jaegere PP; Banga JD; Kappelle LJ; Eikelboom BC; Mali WP; Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2376-82. PubMed ID: 14677480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparticipation cardiovascular screening in competitive athletes: the case in a Greek population.
    Efthimiadis GK; Mezilis N; Meditskou S; Giannakoulas G; Karvounis H; Pliakos C; Parcharidis G
    Scand J Med Sci Sports; 2009 Apr; 19(2):297-8. PubMed ID: 19210669
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening for cardiovascular disease.
    Wierzbicki AS; Twomey PJ; Reynolds TM
    Eur Heart J; 2004 Jun; 25(11):996; author reply 996-7. PubMed ID: 15172476
    [No Abstract]   [Full Text] [Related]  

  • 31. Pre-hypertension and hypertension in pediatrics: don't let the statistics hide the pathology.
    Collins RT; Alpert BS
    J Pediatr; 2009 Aug; 155(2):165-9. PubMed ID: 19619748
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening and management of the workplace for CVD risk.
    Nowack KM; Schnall P; Melamed S; Froom P; Fisher J; Belkić K
    Occup Med; 2000; 15(1):231-56. PubMed ID: 10702088
    [No Abstract]   [Full Text] [Related]  

  • 33. Mild hypertension as a cardiovascular risk factor.
    Kannel WB
    Compr Ther; 1981 Oct; 7(10):7-14. PubMed ID: 7297051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between pre-participation screening of young competitive athletes and family screening.
    van der Werf C; van Langen IM; Wilde AA
    J Am Coll Cardiol; 2009 Jun; 53(24):2309; author reply 2309-10. PubMed ID: 19520259
    [No Abstract]   [Full Text] [Related]  

  • 35. What's new in hypertension?
    Mann JF
    Nephrol Dial Transplant; 2007 Jan; 22(1):47-52. PubMed ID: 17099222
    [No Abstract]   [Full Text] [Related]  

  • 36. A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care.
    Sampson MJ; Barrie P; Dozio N; Flatman M; Hadley-Brown M; Harvey I; Heyburn PJ; Jones C; Mann R; Temple RC; Greenwood RH
    Diabet Med; 2005 Mar; 22(3):256-7. PubMed ID: 15717871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk factor profiles in mild to moderate hypertensives seen at Kenyatta National Hospital.
    Yonga GO; Ogola EN; Juma FD
    East Afr Med J; 1993 Nov; 70(11):693-5. PubMed ID: 8033770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMA policy statement on cardiovascular screening of student athletes.
    Lyznicki JM; Nielsen NH; Schneider JF
    Am Fam Physician; 2000 Aug; 62(4):737-8. PubMed ID: 10969854
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of cardiac complications in neuromuscular disease.
    Lewis WR; Yadlapalli S
    Phys Med Rehabil Clin N Am; 1998 Feb; 9(1):145-66, vii. PubMed ID: 9894138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes.
    Hecht HS
    Circulation; 2001 Sep; 104(11):E58. PubMed ID: 11551892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.